IGF1R and cancer: Except the 1+ lung cancer SBC5 and the gastric cancer IGF-1R-Hs746T animal models, all the other animal models observed potent tumor regression even in the docetaxel-resistant MCF-7 tumor model, showing that W0101 was an IGF-1R dependent and effective compound for cancer therapy [50].